SPDR Advertisement SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

TKMR RSS Feed
Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA, willmakeitrain
Search This Board:
Last Post: 2/27/2015 10:12:13 AM - Followers: 112 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation

 

(TSE:TKM, or US TKMR) 

 

 

http://www.tekmirapharm.com

 

 

 

 

 

Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201

 

As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.

 

Management:   http://www.tekmirapharm.com/Corporate/Management.asp

Pipeline:   http://www.tekmira.com/pipeline/pipeline-products.php 
 

Important Company Highlights: 

LNP Delivery Platform

http://www.tekmira.com/our-science/lnp-delivery-platform.php

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.

  

 

********************************************************************************************

 

Recent News:  

http://tmx.quotemedia.com/news.php?qm_symbol=TKM#page1
http://investor.tekmirapharm.com/releases.cfm
http://finance.yahoo.com/q?s=tkmr&ql=1 

http://www.marketwatch.com/investing/stock/tkmr/news

 ********************************************************************************************

 

Filings: 
http://www.tekmirapharm.com/Investors/Shareholder_Reports.asp

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001447028&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Links of importance for those that trade Canadian stocks:

 Sedar:   http://www.sedar.com/homepage_en.htm

 TMX:.  http://www.tmx.com/

 TMXmoney:   http://www.tmxmoney.com/en/index.html

 CNW Group Newswire:   http://www.cnxmarketlink.com/en/index.cgi

Canadian Insider:    http://canadianinsider.com/coReport/allTransactions.php?ticker=tkm

Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html

 

Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

 
Share Structure:   See filings


Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter: 
http://www.bankofcanada.ca/en/rates/converter.html


 

 

 

 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TKMR
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for TKMR
TKMR News: Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. 02/25/2015 08:00:00 PM
TKMR News: Current Report Filing (8-k) 02/12/2015 05:08:30 PM
TKMR News: Tekmira to Present at RBC Capital Markets' Healthcare Conference 02/12/2015 05:00:00 PM
TKMR News: Current Report Filing (8-k) 02/11/2015 05:02:10 PM
TKMR News: Additional Proxy Soliciting Materials (definitive) (defa14a) 02/11/2015 05:00:25 PM
PostSubject
#4559  Sticky Note Tekmira Announces Licensing and Collaboration Agreement willmakeitrain 11/17/14 08:37:57 AM
#4437  Sticky Note Tekmira to Host Analyst Day on November 21 nanopatent 11/05/14 08:16:42 PM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#4821   Reports on the 500 doses of TKMR EBOLA Echo20 02/27/15 10:12:13 AM
#4820   stockcharts.com/c-sc/sc?s=tkmr&p=D&b=5&g=0&i=t52238083180&r=4082 mick 02/25/15 01:35:56 PM
#4819   Support is broken Dr_Thorfin 02/25/15 12:21:12 PM
#4818   TKMR Tekmira Pharmaceuticals Corporation mick 02/23/15 07:57:19 PM
#4817   Overviews are great. nanopatent 02/23/15 08:31:08 AM
#4816   tomorrow we have a company overview at the Dr_Thorfin 02/23/15 06:43:12 AM
#4815   few weeks of consollidation after that huge jump Dr_Thorfin 02/21/15 06:23:12 AM
#4814   Ready to bounce Dr_Thorfin 02/20/15 05:59:54 PM
#4813   Tekmira Pharmaceuticals Corporation Analyst Rating Update nanopatent 02/20/15 03:52:31 PM
#4812   bounce of MA50 ?? Dr_Thorfin 02/20/15 10:46:41 AM
#4811   Current Report Filing (8-k) "Edgar (US Regulatory)" - mick 02/13/15 01:46:13 PM
#4810   Tekmira Pharmaceutic (TKMR) mick 02/13/15 01:45:18 PM
#4809   Tekmira Pharmaceuticals Corporation (TKMR) mick 02/13/15 01:44:34 PM
#4808   Gilead ( GILD) Agrees to a Discounted Price nanopatent 02/13/15 10:14:52 AM
#4807   Tekmira Announces Filing of Definitive Proxy Statement and John-Knee 02/04/15 10:21:26 PM
#4806   Is news nearby? muggel 02/04/15 11:01:40 AM
#4805   http://www.benzinga.com/trading-ideas/long-ideas/15/02/5202482/the-3-best-biotec muggel 02/04/15 07:59:20 AM
#4804   stockcharts.com/c-sc/sc?s=tkmr&p=D&yr=0&mn=6&dy=0&i=p74497321793&r=139763 mick 02/03/15 01:20:06 PM
#4803   On the technical charting; support levels are 23.30, John-Knee 02/03/15 10:37:14 AM
#4802   Karen.... Are you expecting the price to maxinvest 02/03/15 08:23:18 AM
#4801   Nanopatent There are some 500 doses of TKMR EBOLA Echo20 02/02/15 12:20:01 PM
#4800   As per the usual with these lol TradeSmart 02/02/15 12:09:33 PM
#4799   A hit piece or two is about to KarinCA 02/02/15 11:54:31 AM
#4797   http://www.bbc.com/news/world-africa-31087727 muggel 02/02/15 06:51:45 AM
#4796   $TKMR short interest increased 70% in the last TradeSmart 02/02/15 05:42:01 AM
#4795   What makes America great. nanopatent 01/29/15 01:46:56 PM
#4794   TKMR impresses me! nanopatent 01/29/15 01:41:42 PM
#4793   Tekmira Pharmaceutic (TKMR) mick 01/27/15 02:33:49 PM
#4792   Tekmira Pharmaceuticals Corporation (TKMR): Falcon Edge Capital Discloses nanopatent 01/26/15 09:08:54 PM
#4791   Tekmira Aims to Follow Path Blazed in HCV nanopatent 01/26/15 09:04:38 PM
#4790   https://propthink.com/consider-2-3x-upside-overlooked-hepatitis-b-stock muggel 01/26/15 05:44:15 PM
#4789   nice read Dr_Thorfin 01/26/15 04:38:23 AM
#4788   https://propthink.com/new-tekmira-emerges-hbv-frontrunner/ muggel 01/25/15 04:33:34 PM
#4787   Reasons for the Merger nanopatent 01/24/15 12:42:16 PM
#4786   For HBV - two heads are way better nanopatent 01/23/15 08:48:54 PM
#4785   can someone explain this filing to me and quick? HD3369 01/23/15 08:35:00 PM
#4784   Im pretty sure it'll hold. Just a pullbacl spades 01/23/15 07:40:41 PM
#4783   AVG volume (30D) = 1,343,066 Dr_Thorfin 01/23/15 02:28:12 PM
#4782   Don't forget volume to confirm breakout. John-Knee 01/23/15 02:01:12 PM
#4781   25 resistance broken, if it holds we have Dr_Thorfin 01/23/15 01:53:47 PM
#4780   TKMR 25.8 hitting it spades 01/23/15 12:08:12 PM
#4779   hope we breakout soon,hate the manipulation during first Dr_Thorfin 01/22/15 09:46:02 AM
#4778   It's hard to figure just how high this nanopatent 01/22/15 09:30:31 AM
#4777   saw that filling too Dr_Thorfin 01/22/15 06:08:09 AM
#4776   TKMR 24.2 wedge setting up. Target 32 spades 01/21/15 11:39:45 PM
#4775   It was revealed in a filing yesterday with nanopatent 01/21/15 09:54:27 PM
#4774   $94,500 sounds like a lot BUT once cured nanopatent 01/21/15 09:48:45 PM
#4773   $94,500 for one 12 week treatment? Dr_Thorfin 01/21/15 05:44:07 PM
#4772   When I see that for a typical 12-week nanopatent 01/21/15 03:43:39 PM
#4771   nice run leading to the closing bell Dr_Thorfin 01/21/15 03:05:13 PM
PostSubject